NEWS

Addressing P1 Occlusion

NeVa CLEAR Study results presented at ESMINT: innovative thrombectomy de...

DALLAS, TEXAS- (September 21, 2023) – The NeVa CLEAR Study is a prospective, multicenter, open-label, single-arm, FDA-regulated IDE trial evaluating the safety and effectiveness of Vesalio’s technologically advanced NeVa device, renowned for its capacity to retrieve all clot types in large vessel occlusion (LVO) stroke. Primary results from the study were presented at the ESMINT annual meeting in Marseille, France (4-6 September 2023), where Vesalio also announced the fifth anniversary of NeVa’s international commercialization, making this milestone a dual celebration for the Vesalio team.

Indications of intra-cranial stenting for failed thrombectomy

Remodeling technique - a blessing with a risk

“Tough clots" special feature: uncovering clinical evidence

Radial access: an INR breakthrough?

Tribute to Juha Hernesniemi

LINNCing clot composition and clinical outcomes

Intravascular Imaging in Neuro

SENSOME and ASAHI INTECC forge partnership to develop next-generation sm...

PARIS, FRANCE - JUNE 21ST , 2023 – Pioneering smart medical device company, Sensome, and worldleading Japanese guidewire company, Asahi Intecc, are announcing today a collaboration to develop the next generation Clotild® Smart Guidewire, with Asahi Intecc taking on the manufacturing role for this groundbreaking device destined for the treatment of acute ischemic stroke.